How ‘race-norming’ was built into the NFL concussion settlement
By Will Hobson,
The Washington Post
| 08. 02. 2021
The NFL and lawyers for former players blame the controversial practice on doctors. But both sides negotiated a settlement that guaranteed race would affect payouts — and defended the practice long after concerns were raised.
Licensed for use by CC BY-SA 2.0 on Wikimedia Commons
CHANDLER, Ariz. — At first glance, Rick Cunningham looks almost as formidable at 54 as he did during his playing days.
As the 6-foot-7, 270-pound former offensive tackle led a visitor into his home recently, the only visible sign that eight seasons in the National Football League inflicted any lasting damage was Cunningham’s deliberate gait, caused by chronic pain in knees surgically repaired nine times and hips that need replacing.
Then Cunningham tried to speak. Thoughts form in his head, he explained, but he has trouble finding the words. He stammered often, sometimes relying on his wife, Debbie, to translate. At one point, he gestured toward a pool table and explained — in a belabored, meandering way — that he couldn’t remember what to call the wooden pole resting across it.
“It’s a pool cue, hon,” Debbie said as she gently held his arm.
When the settlement in the landmark NFL class-action concussion litigation was finalized in 2017, and the league agreed to pay sums as high as $5...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...